On February 4, 2021, Plus Products Inc. (OTCQX: PLPRF) announced a partnership with CannRx Biosciences to enhance product delivery using CannRx's patented CannTrap technology. This innovation aims to improve the bioavailability of cannabinoids, allowing for faster onset effects in products like gummies and beverages. The collaboration is expected to expand formulation opportunities and reduce dosing for desired effects. Leadership from both companies emphasizes a commitment to quality and innovation in the cannabis sector.
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) announces a meeting for holders of its 8.00% unsecured convertible debentures on February 25, 2021. Key proposals include extending the maturity date to February 28, 2024, increasing the coupon rate from 8.00% to 12.00%, granting a security interest in the Company’s assets, and modifying conversion rights. The Board recommends that Debentureholders vote in favor of the proposed amendments. These actions aim to enhance the Company’s financial stability and support future growth.